A clinical study on efficacy and safety of dopamine replacement therapy for drug-induced parkinsonism
Not Applicable
Recruiting
- Conditions
- Drug-induced parkinsonism
- Registration Number
- JPRN-UMIN000038397
- Lead Sponsor
- Tokyo Metropolitan Matsuzawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Orthopedic conditions which preclude quantitative neurological assessments, such as fractures and severe arthralgia. 2. Severe intellectual disabilities which preclude accurate neurological assessments. 3. History of alcohol or other substance abuse. 4. Patients who are already diagnosed as having organic neurological diseases, or whose CT/MRI scans demonstrate cerebrovascular diseases (excluding a few to several numbers of small infarcts or microbleeds) or severe brain atrophy. 5. Patients who take levodopa or dopamine receptor agonists at the baseline assessment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method